Form 4: Surrozen Director Boosts Stake via Fund Purchases

Surrozen Director and 10% owner Tim Kutzkey, through affiliated investment funds, acquired additional common stock in the company on January 13 and 14, 2026.

Summary

• Tim Kutzkey, a Director and 10% owner of Surrozen, Inc. (SRZN), reported indirect purchases of common stock.
• On January 13, 2026, 5,861 shares were acquired by The Column Group III, LP at a price of $19.8041 per share, and 6,609 shares were acquired by The Column Group III-A, LP at the same price.
• On January 14, 2026, an additional 2,596 shares were acquired by The Column Group III, LP at $19.9883 per share, and 2,927 shares were acquired by The Column Group III-A, LP at the same price.
• Following these transactions, The Column Group III, LP beneficially owns 885,014 shares, and The Column Group III-A, LP beneficially owns 999,429 shares.
• The Column Group Opportunity III, LP also beneficially owns 344,827 shares, bringing the total indirect beneficial ownership through these entities to 2,229,270 shares.
• Mr. Kutzkey is a managing partner of the general partners of these investment funds and disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a director and significant owner, even indirectly through investment funds, typically signals confidence in the company's future prospects and valuation, contributing to a positive sentiment.

Positives

• A director and significant owner increasing their stake in the company, even indirectly, can signal confidence in the company's future prospects and valuation.
• The purchases were made at market prices of $19.8041 and $19.9883, indicating a belief in the current valuation or potential for appreciation.

Future Outlook

This filing is a transaction report and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider purchases, particularly by directors and significant shareholders, are often interpreted by the market as a positive signal, suggesting that those closest to the company believe its stock is undervalued or poised for growth. In the biotechnology sector, such signals can be particularly impactful given the long development cycles and inherent risks.

Related Party Transactions

• The reported transactions involve the indirect acquisition of shares by Tim Kutzkey through investment funds (The Column Group III, LP, The Column Group III-A, LP, and The Column Group Opportunity III, LP) where he serves as a managing partner of their respective general partners. This structure indicates a related party relationship for the beneficial ownership of these securities.

Stakeholder Impact

• Shareholders may view the insider buying as a positive indicator of management's belief in the company's value and future performance, potentially boosting investor confidence.

Key Dates

Recommendation

While insider buying by a director and 10% owner is generally viewed as a positive signal, indicating management's confidence in the company's future, this single transaction report does not provide sufficient information to warrant a 'buy' or 'strong buy' recommendation. Investors should consider this alongside comprehensive financial performance, strategic outlook, and broader market conditions before making investment decisions. A 'hold' recommendation acknowledges the positive signal while advising further due diligence.

Keywords

Surrozen, SRZN, Insider Trading, Form 4, Stock Purchase, Director Ownership, The Column Group, Biotechnology, SEC Filing